HEALTH

Boston Medical Group report underscores sexual health

BY Michael Johnsen

LOS ANGELES Boston Medical Group, a national physician network specializing in the treatment of erectile dysfunction and premature ejaculation, on Monday released 10 leading reasons regular sexual activity can help improve men’s overall health.

“It’s a well-known stereotype that men don’t need more reasons to have sex, but it’s important to remember that regular sexual activity is more than recreational – good sexual health is vital to a man’s overall physical, psychological and emotional health,” stated Barry Buffman, a physician at Boston Medical Group. “Sex can benefit everything from a man’s short term mood, to longer term issues like cardiovascular health and the reduced risk of prostate cancer.”

The full list of health benefits includes continued intimacy health later into life; a 30% reduction in prostate cancer risk; increased testosterone production, which can strengthen bones and muscles; improved cardiovascular health; a boosted immunity system; pain relief; and better sleep.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Walgreens gets in the holiday spirit

BY Alaric DeArment

Walgreens is promoting general merchandise and personal care products with its ‘Big Joy. Little Prices’ campaign.

The campaign is a way for Walgreens to drive sales by promoting everyday, front-end items ranging from shampoo to diapers.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Quigley to tap into OTC market

BY Michael Johnsen

DOYLESTOWN, Pa. Quigley plans to focus on product developments in the over-the-counter arena, as opposed to developing prescription drug products, the company announced Thursday.

Though Quigley will continue to pursue the prescription-only development of QR333, a medicine for the symptomatic relief of diabetic peripheral neuropathy; QR440, a remedy for relief of inflammation and joint pain; and QR448, an anti-infective against infectious bronchitis in poultry.

Ted Karkus, Quigley chairman and CEO, suggested that Quigley would be placing the lion’s share of its investment behind brand development of Cold-Eeze. “We are particularly interested in leveraging our distribution network in mass, pharmacy and grocery retail by acquiring or developing additional personal care and OTC products,” he said. “We are aggressively searching for product acquisitions and researching line extensions of our Cold-Eeze and Kids-Eeze brands to accomplish these goals, diversify our product offerings and to set the stage for future growth of our company.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?